Barbara Voetsch, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vertigo | 2 | 2021 | 205 | 0.770 |
Why?
|
| Somatosensory Disorders | 1 | 2021 | 49 | 0.730 |
Why?
|
| Dizziness | 2 | 2021 | 269 | 0.700 |
Why?
|
| Glutathione Peroxidase | 5 | 2007 | 259 | 0.680 |
Why?
|
| Neurologic Examination | 2 | 2021 | 913 | 0.660 |
Why?
|
| Intracranial Thrombosis | 5 | 2020 | 109 | 0.590 |
Why?
|
| Stroke | 15 | 2024 | 9746 | 0.520 |
Why?
|
| Thrombophilia | 4 | 2007 | 308 | 0.430 |
Why?
|
| Brain Ischemia | 6 | 2022 | 3001 | 0.410 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2011 | 50 | 0.370 |
Why?
|
| Thrombectomy | 4 | 2024 | 676 | 0.360 |
Why?
|
| Arteriosclerosis | 2 | 2004 | 1055 | 0.340 |
Why?
|
| Polymorphism, Genetic | 3 | 2006 | 4247 | 0.330 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2021 | 1023 | 0.330 |
Why?
|
| Vasospasm, Intracranial | 1 | 2011 | 207 | 0.320 |
Why?
|
| Intracranial Aneurysm | 2 | 2021 | 1271 | 0.280 |
Why?
|
| Aryldialkylphosphatase | 2 | 2004 | 64 | 0.270 |
Why?
|
| Thrombolytic Therapy | 4 | 2024 | 2054 | 0.270 |
Why?
|
| Promoter Regions, Genetic | 4 | 2007 | 5796 | 0.260 |
Why?
|
| Venous Thrombosis | 4 | 2007 | 1321 | 0.240 |
Why?
|
| Infarction, Posterior Cerebral Artery | 1 | 2004 | 15 | 0.230 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2004 | 112 | 0.210 |
Why?
|
| Intracranial Embolism | 2 | 2020 | 188 | 0.210 |
Why?
|
| Esterases | 1 | 2002 | 89 | 0.200 |
Why?
|
| Blood Vessels | 2 | 2004 | 1110 | 0.190 |
Why?
|
| Hemodynamics | 1 | 2011 | 4186 | 0.180 |
Why?
|
| Central Nervous System Infections | 1 | 2021 | 61 | 0.180 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2021 | 1164 | 0.180 |
Why?
|
| Open Reading Frames | 1 | 2004 | 818 | 0.180 |
Why?
|
| Thrombosis | 2 | 2004 | 2954 | 0.170 |
Why?
|
| Arteries | 2 | 2002 | 1123 | 0.170 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2003 | 743 | 0.160 |
Why?
|
| Middle Cerebral Artery | 3 | 2011 | 271 | 0.160 |
Why?
|
| Nitric Oxide | 2 | 2005 | 2140 | 0.160 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2020 | 485 | 0.150 |
Why?
|
| Paresis | 2 | 2011 | 177 | 0.150 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 1493 | 0.150 |
Why?
|
| Fibrinolytic Agents | 3 | 2024 | 2079 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2007 | 18063 | 0.140 |
Why?
|
| Gene Frequency | 4 | 2006 | 3621 | 0.130 |
Why?
|
| Intracranial Hemorrhages | 1 | 2021 | 810 | 0.120 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2021 | 616 | 0.120 |
Why?
|
| Apolipoprotein E4 | 1 | 2018 | 709 | 0.110 |
Why?
|
| Carotid Artery Diseases | 1 | 2020 | 872 | 0.110 |
Why?
|
| Cerebral Angiography | 2 | 2011 | 1263 | 0.110 |
Why?
|
| Glucosephosphate Dehydrogenase | 2 | 2005 | 209 | 0.100 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2011 | 54 | 0.100 |
Why?
|
| Ischemia | 1 | 2000 | 1905 | 0.090 |
Why?
|
| Haplotypes | 2 | 2007 | 2722 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2018 | 1806 | 0.090 |
Why?
|
| Registries | 2 | 2021 | 8351 | 0.090 |
Why?
|
| Dominance, Cerebral | 1 | 2011 | 616 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1895 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2024 | 20741 | 0.090 |
Why?
|
| Cerebellum | 1 | 2017 | 1521 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 2021 | 2416 | 0.080 |
Why?
|
| Blood Patch, Epidural | 1 | 2009 | 57 | 0.080 |
Why?
|
| Intracranial Hypotension | 1 | 2009 | 42 | 0.080 |
Why?
|
| Demography | 2 | 2004 | 1641 | 0.080 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 1479 | 0.070 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2007 | 62 | 0.070 |
Why?
|
| Antioxidants | 2 | 2006 | 1671 | 0.070 |
Why?
|
| Risk Factors | 11 | 2020 | 74886 | 0.070 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2007 | 325 | 0.070 |
Why?
|
| Humans | 35 | 2024 | 767040 | 0.070 |
Why?
|
| Spinal Puncture | 1 | 2009 | 284 | 0.070 |
Why?
|
| Brazil | 2 | 2002 | 1250 | 0.070 |
Why?
|
| Logistic Models | 3 | 2007 | 13284 | 0.060 |
Why?
|
| Coagulation Protein Disorders | 1 | 2004 | 6 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2017 | 2811 | 0.060 |
Why?
|
| Cranial Sinuses | 1 | 2004 | 68 | 0.060 |
Why?
|
| Hospitalization | 2 | 2021 | 10815 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2018 | 5914 | 0.060 |
Why?
|
| Epoprostenol | 1 | 2005 | 246 | 0.060 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 7871 | 0.060 |
Why?
|
| Hormones | 1 | 2007 | 865 | 0.060 |
Why?
|
| Adult | 14 | 2021 | 223317 | 0.050 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2004 | 138 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2021 | 36582 | 0.050 |
Why?
|
| Fibrinolysis | 1 | 2004 | 331 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3112 | 0.050 |
Why?
|
| Middle Aged | 14 | 2024 | 223233 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3234 | 0.050 |
Why?
|
| Apyrase | 1 | 2005 | 376 | 0.050 |
Why?
|
| Cerebral Infarction | 2 | 2005 | 968 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 1168 | 0.050 |
Why?
|
| Female | 18 | 2024 | 396660 | 0.050 |
Why?
|
| Endarterectomy, Carotid | 1 | 2007 | 556 | 0.050 |
Why?
|
| Male | 18 | 2024 | 364203 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 911 | 0.050 |
Why?
|
| Hyperhomocysteinemia | 1 | 2002 | 117 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2004 | 706 | 0.050 |
Why?
|
| Retrospective Studies | 8 | 2024 | 81659 | 0.050 |
Why?
|
| Glutamine | 1 | 2004 | 575 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2004 | 9660 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2006 | 3587 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 671 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2007 | 1408 | 0.040 |
Why?
|
| Pandemics | 4 | 2021 | 8736 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 1751 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 2006 | 1163 | 0.040 |
Why?
|
| Cerebral Veins | 1 | 2002 | 157 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2006 | 2602 | 0.040 |
Why?
|
| Arginine | 1 | 2004 | 931 | 0.040 |
Why?
|
| Lymphokines | 1 | 2003 | 924 | 0.040 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2000 | 62 | 0.040 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2004 | 519 | 0.040 |
Why?
|
| Alleles | 2 | 2002 | 6893 | 0.040 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 26325 | 0.040 |
Why?
|
| Prothrombin | 1 | 2000 | 194 | 0.040 |
Why?
|
| Factor V | 1 | 2000 | 168 | 0.040 |
Why?
|
| Recurrence | 1 | 2011 | 8504 | 0.040 |
Why?
|
| Aged, 80 and over | 6 | 2024 | 59548 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2011 | 3370 | 0.040 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2000 | 276 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 1 | 2004 | 874 | 0.040 |
Why?
|
| Genotype | 2 | 2004 | 13035 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 4052 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2004 | 2920 | 0.040 |
Why?
|
| Aged | 10 | 2024 | 171319 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 4114 | 0.040 |
Why?
|
| Palmitic Acid | 1 | 2018 | 148 | 0.040 |
Why?
|
| Linoleic Acid | 1 | 2018 | 158 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 1743 | 0.040 |
Why?
|
| Africa | 1 | 2000 | 725 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2009 | 1936 | 0.040 |
Why?
|
| Contraceptives, Oral | 1 | 2000 | 560 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2018 | 430 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 2144 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2007 | 2672 | 0.030 |
Why?
|
| North America | 1 | 2020 | 1287 | 0.030 |
Why?
|
| Living Donors | 1 | 2021 | 647 | 0.030 |
Why?
|
| Nystagmus, Pathologic | 1 | 2017 | 104 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1655 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2003 | 1368 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2011 | 8531 | 0.030 |
Why?
|
| Canada | 1 | 2021 | 2127 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2021 | 1079 | 0.030 |
Why?
|
| Endothelium, Vascular | 2 | 2005 | 4424 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2007 | 2655 | 0.030 |
Why?
|
| Homozygote | 1 | 2000 | 1774 | 0.030 |
Why?
|
| Family Health | 1 | 2000 | 1254 | 0.030 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2017 | 243 | 0.030 |
Why?
|
| Tinnitus | 1 | 2017 | 197 | 0.030 |
Why?
|
| Point Mutation | 1 | 2000 | 1591 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 6067 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2005 | 4032 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2005 | 2464 | 0.030 |
Why?
|
| Treatment Outcome | 6 | 2022 | 65295 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2017 | 640 | 0.030 |
Why?
|
| Prevalence | 2 | 2002 | 15851 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2007 | 2598 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2005 | 3139 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2004 | 2783 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2006 | 3591 | 0.030 |
Why?
|
| Brain | 3 | 2009 | 27163 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2021 | 54886 | 0.030 |
Why?
|
| Cleft Lip | 1 | 2018 | 512 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 4780 | 0.030 |
Why?
|
| Adolescent | 4 | 2007 | 89046 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2000 | 1198 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2017 | 679 | 0.030 |
Why?
|
| Retinal Diseases | 1 | 2018 | 709 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 2276 | 0.020 |
Why?
|
| Docosahexaenoic Acids | 1 | 2018 | 914 | 0.020 |
Why?
|
| Risk | 1 | 2004 | 9606 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2000 | 1161 | 0.020 |
Why?
|
| Age Distribution | 1 | 2017 | 2870 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2004 | 10092 | 0.020 |
Why?
|
| Boston | 1 | 2004 | 9360 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2018 | 2001 | 0.020 |
Why?
|
| Endovascular Procedures | 1 | 2024 | 2215 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1997 | 1478 | 0.020 |
Why?
|
| Time Factors | 3 | 2021 | 40154 | 0.020 |
Why?
|
| Survival Rate | 1 | 2004 | 12823 | 0.020 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2009 | 38 | 0.020 |
Why?
|
| Head-Down Tilt | 1 | 2009 | 67 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 5754 | 0.020 |
Why?
|
| Hernia | 1 | 2009 | 67 | 0.020 |
Why?
|
| Child | 3 | 2006 | 80771 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2004 | 10455 | 0.020 |
Why?
|
| Prognosis | 3 | 2005 | 29963 | 0.020 |
Why?
|
| Comorbidity | 1 | 2002 | 10582 | 0.020 |
Why?
|
| Mortality | 1 | 2018 | 2909 | 0.020 |
Why?
|
| Unconsciousness | 1 | 2009 | 251 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2004 | 22254 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2007 | 527 | 0.020 |
Why?
|
| Mutation | 2 | 2007 | 30211 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2021 | 4854 | 0.020 |
Why?
|
| Animals | 4 | 2004 | 168965 | 0.020 |
Why?
|
| Brain Edema | 1 | 2009 | 601 | 0.010 |
Why?
|
| Catalase | 1 | 2005 | 215 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2005 | 94 | 0.010 |
Why?
|
| Craniotomy | 1 | 2009 | 736 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2000 | 6611 | 0.010 |
Why?
|
| Age Factors | 1 | 2021 | 18401 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2004 | 42606 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2009 | 2227 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12536 | 0.010 |
Why?
|
| Transcription Initiation Site | 1 | 2004 | 190 | 0.010 |
Why?
|
| Tremor | 1 | 2004 | 196 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 2004 | 302 | 0.010 |
Why?
|
| Selenocysteine | 1 | 2004 | 127 | 0.010 |
Why?
|
| Ear Diseases | 1 | 2004 | 181 | 0.010 |
Why?
|
| Sulfhydryl Compounds | 1 | 2004 | 296 | 0.010 |
Why?
|
| United States | 2 | 2021 | 72971 | 0.010 |
Why?
|
| Luciferases | 1 | 2004 | 713 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2005 | 596 | 0.010 |
Why?
|
| Perfusion | 1 | 2007 | 1409 | 0.010 |
Why?
|
| Ataxia | 1 | 2004 | 307 | 0.010 |
Why?
|
| Pregnancy | 2 | 2004 | 30238 | 0.010 |
Why?
|
| RNA, Transfer | 1 | 2004 | 284 | 0.010 |
Why?
|
| Infant | 1 | 2004 | 36485 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2004 | 661 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 748 | 0.010 |
Why?
|
| Syndrome | 1 | 2007 | 3271 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 1989 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2002 | 24299 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2003 | 462 | 0.010 |
Why?
|
| Smoking | 1 | 2017 | 9081 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 1526 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2004 | 966 | 0.010 |
Why?
|
| Carotid Stenosis | 1 | 2007 | 858 | 0.010 |
Why?
|
| Severity of Illness Index | 3 | 2005 | 15925 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2017 | 13048 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 15645 | 0.010 |
Why?
|
| Cattle | 1 | 2003 | 3813 | 0.010 |
Why?
|
| Hypertension | 1 | 2017 | 8615 | 0.010 |
Why?
|
| Headache | 1 | 2004 | 1261 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 5753 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 4473 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 6014 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2004 | 1889 | 0.010 |
Why?
|
| Heart Rate | 1 | 2005 | 4209 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 6975 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 59980 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 12414 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 3511 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 17608 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 7587 | 0.010 |
Why?
|
| Cell Movement | 1 | 2003 | 5203 | 0.010 |
Why?
|
| Pain | 1 | 2004 | 5101 | 0.010 |
Why?
|
| Cell Line | 1 | 2003 | 15567 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12986 | 0.000 |
Why?
|
| Kidney | 1 | 2004 | 7063 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2009 | 15824 | 0.000 |
Why?
|
| Disease Progression | 1 | 2002 | 13646 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2004 | 39317 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1997 | 15424 | 0.000 |
Why?
|